Is Clever Leaves Holdings Inc (CLVR) overvalued? · rev $17.4M
Clever Leaves Holdings Inc (CLVR) is a drug manufacturers - specialty & generic company listed on US.
This page asks whether Clever Leaves Holdings Inc (CLVR) looks expensive on cached numbers — not a short thesis.
Latest reported CLVR revenue for 2023-12-31 was $17.4M. Net income was -$17.9M. Revenue was up 6.1% from 2022-12-31 to 2023-12-31. CLVR currently screens at market cap $1.4K.
CLVR currently screens at market cap $1.4K. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CLVR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CLVR stock page for the full model, not this heading.
Not investment advice.